Finance Home - My Yahoo - Yahoo! - Help

Monday, November 30, 2009, 11:46AM ET - U.S. Markets close in 4 hours and 14 minutes. Dow  0.29% Nasdaq  0.69%

Maxygen, Inc. (MAXY)

At 11:31AM ET: 5.41   0.17 (3.05%)

MORE ON MAXY

Quotes Summary Real-Time Options Historical Prices Charts Interactive Basic Chart Basic Tech. Analysis News & Info Headlines Financial Blogs Company Events Message Board Company Profile Key Statistics SEC Filings Competitors Industry Components Analyst Coverage Analyst Opinion Analyst Estimates Research Reports Star Analysts Ownership Major Holders Insider Transactions Insider Roster Financials Income Statement Balance Sheet Cash Flow

Competitors Get Competitors for:
DIRECT COMPETITOR COMPARISON   MAXY LLY Pvt1 HGSI Industry Market Cap: 208.03M 42.08B N/A 4.50B 77.93M Employ­ees: 72 40,500 11,1741 880 217 Qtrly Rev Growth (yoy): -91.50% 6.80% N/A 61.30% 11.90% Revenue (ttm): 29.08M 21.11B 13.42B1 235.70M 56.04M Gross Margin (ttm): 45.94% 82.33% N/A 10.36% 35.56% EBITDA (ttm): -23.66M 7.74B N/A -8.22M -1.94M Oper Margins (ttm): -85.08% 30.97% N/A -12.73% -11.79% Net Income (ttm): -36.38M -216.00M N/A -22.51M N/A EPS (ttm): -0.960 -0.197 N/A -0.160 N/A P/E (ttm): N/A N/A N/A N/A 18.85 PEG (5 yr expected): N/A 4 N/A 186.4 1.43 P/S (ttm): 7.38 2.01 N/A 18.98 1.80 LLY = Eli Lilly & Co. Pvt1 = Genentech, Inc. (privately held) HGSI = Human Genome Sciences Inc. Industry = Research Services 1 = As of 2008   NEWS ON DIRECT COMPETITORS   • LLY Johnson & Johnson: Good & Bad News Mon 10:47am - at TheStreet.com • LLY Biotech Calendar: Key Dates for December Mon 9:56am - at TheStreet.com • LLY Eli Lilly's Cymbalta gets additional FDA approval Mon 8:18am - AP • LLY InPlay: Eli Lilly: FDA approves Cymbalta for maintenance treatment of Generalized Anxiety Disorder Mon 8:00am - Briefing.com • LLY FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder Mon 8:00am - PR Newswire • HGSI [$$] This Isn't 2003 Fri, Nov 27 - at RealMoney by TheStreet.com • HGSI Human Genome Sciences seeks approval for Zalbin Wed, Nov 25 - AP • HGSI Human Genome Sciences Submits Biologics License Application to FDA for ZALBIN Wed, Nov 25 - Business Wire • HGSI Best Performing U.S. Stocks Year to Date Tue, Nov 24 - at Seeking Alpha • HGSI Signals Favor a Santa Claus Rally Tue, Nov 24 - at Minyanville.com • HGSI Wall Street's Buy List Tue, Nov 24 - at Motley Fool All Headlines for these symbols... Need more? Get unbiased, in-depth information on public and private companies worldwide from Hoover's Online.
Add to Portfolio     Set Alert     Email to a Friend Get Competitors for Another Symbol: Symbol Lookup • Stock Screener • Sector Analysis